Photostimulation of Mitochondria as a Treatment for Retinal Neurodegeneration. Beirne et al. 2017
Absorption of photon energy by neuronal mitochondria leads to numerous downstream neuroprotective effects.
670nm PBM reduces inflammation and upregulates cytochrome c oxidase in AMD model, Begum et al 2013
670 nm light upregulated cytochrome c oxidase and reduced retinal inflammation, providing mechanistic foundation for clinical AMD PBM outcomes.
Photobiomodulation for dry AMD – Toronto & Oak Ridge Study (Merry et al. 2012)
PBM using 670 nm combined with lower-fluence 590/790 nm exposure demonstrated clinically meaningful and statistically significant improvements in visual function, with benefits persisting up to one year.
Low-level laser therapy improves vision in patients with age-related macular degeneration. Ivandic et al. 2008
the findings highlight that mitochondria-responsive wavelengths in the red/NIR range can drive functional benefits in retinal tissue when delivered within safe fluence windows.
Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration Janos Feher, Illes Kovacs et al 2006
This foundational study characterized mitochondrial structural/functional deficits in AMD RPE, establishing mitochondrial dysfunction as a key therapeutic target for PBM.
Blue light exacerbates and red light counteracts negative insults to retinal ganglion cells, Núñez-Álvarez, N N Osborne 2019
Red light (630-670 nm) counteracted blue light toxicity in retinal ganglion cells through enhanced ATP, increased antioxidants, and mitochondrial protection.
Aging retinal function is improved by near infrared light (670nm) with corrected mitochondrial decline. Sivapathasuntharam et al. 2017
These findings reinforce the concept that mitochondrial-targeted photobiomodulation can partially reverse age-related retinal decline and may have implications for managing retinal aging and age-related disease such as AMD.
Visual light effects on mitochondria and glaucoma, Osborne et al., 2016
Red and near-infrared wavelengths (650–800 nm) were shown to activate cytochrome c oxidase (Complex IV), increase ATP production, and promote mitochondrial resilience. In ischemic RGC models, additional long-wavelength light exposure preserved mitochondrial function and improved cellular survival.
Vitamin D rejuvenates aging eyes by reducing inflammation, clearing amyloid beta and improving visual function Vivian Lee et al 2012
These results connect systemic immune modulation with retinal mitochondrial health and inflammatory load—two major contributors to age-related macular degeneration (AMD) progression.
Targeting mitochondrial function to treat optic neuropathy, Gueven et al., 2016
Photobiomodulation offers broad applicability for optic neuropathies through cytochrome c oxidase activation, with advantages over pharmacological interventions.
“`
